Global Clot Busting Drugs Market Size study & Forecast, by Product by Indication, by Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Clot Busting Drugs Market is valued at approximately USD 28.6 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2023-2030. Clot-busting drugs are medications used to dissolve blood clots in a medical emergency. These drugs work by activating the body's natural clot-dissolving system, known as fibrinolysis, to break down the fibrin meshwork that forms blood clots. The most used clot-busting drug is tissue plasminogen activator (tPA), also called alteplase. tPA is a naturally occurring protein in the body that helps dissolve blood clots. The Clot Busting Drugs market is expanding because of factors such as the increasing incidence of thrombotic disorders and government initiatives and funding for the development of thrombolytic drugs.

The rising prevalence of cardiovascular diseases, deep vein thrombosis, pulmonary embolism, and ischemic stroke has led to an increased demand for clot-busting drugs. These conditions require immediate treatment to dissolve blood clots and restore blood flow, thereby driving market growth. The Global Stroke Factsheet released in 2022 reveals that the risk for developing stroke has increased by 50% over the last 17 years and as of year 2022, 1 in 4 people is estimated to have a stroke in their lifetime. Furthermore, according to World Health Organization Report 2020 around 17.9 million lives each year are being suffered from heart disorders across the globe. Thus rising prevalence of thrombotic disorders such as cardiovascular diseases and ischemic stroke is driving the market growth. In addition, advancements in clot-busting drug therapies and rising awareness and diagnosis of clotting disorders are creating a lucrative opportunity for market growth. However, the high cost of Clot Busting Drugs and advancements in interventional procedures: stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clot Busting Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, increasing disease prevalence, and a rising number of research and development activities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising geriatric, increasing prevalence of diseases, an increase in the number of collaborations for product development, and active participation of government and private organizations in the market space.

Major market players included in this report are:

Bayer AG
Merck & Co
Sun Pharmaceutical Industries Ltd.
Johnson & Johnson Services Inc
Sanofi-Aventis S.A
Boehringer Ingelheim Gmbh
Dr. Reddy's Laboratories
Genentech Inc.
Pfizer Inc.
Eli Lilly and Company

Recent Developments in the Market:

In December 2021, The U.S. FDA approved XARELTO (rivaroxaban), an oral anticoagulant manufactured by Janssen Pharmaceutical. The medication has two pediatric indications, including the prevention of deep vein thrombosis (DVT) that causes pulmonary embolism.
In June 2021, Boehringer Ingelheim released dabigatran etexilate, the active ingredient in Pradaxa. Pradaxa oral pellets were given FDA approval to treat venous thromboembolism, a condition in which blood clots develop in the veins, in children three months to under twelve years old.

Global Clot Busting Drugs Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Indication, Route of Administration, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Thrombolytic Drugs
Anti-Platelet Drugs
Anticoagulants
Others

By Indication:

Deep Vein Thrombosis
Atrial Fibrillation
Pulmonary Embolism
Others

By Route of Administration:

Oral
Injectable

By Distribution Channel:

Hospital Pharmacy
Drug Store
Online Pharmacy
Retail Pharmacy

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Clot Busting Drugs Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Clot Busting Drugs Market, by Product, 2020-2030 (USD Billion)
- 1.2.3. Clot Busting Drugs Market, by Indication, 2020-2030 (USD Billion)
- 1.2.4. Clot Busting Drugs Market, by Route of Administration, 2020-2030 (USD Billion)
- 1.2.5. Clot Busting Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Clot Busting Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Clot Busting Drugs Market Dynamics

3.1. Clot Busting Drugs Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of thrombotic disorders
  - 3.1.1.2. Government initiatives and funding for the development of thrombolytic drugs
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Clot-Busting Drugs

3.1.2.2. Advancements in interventional procedures:

3.1.3. Market Opportunities
- 3.1.3.1. Advancements in clot-busting drug therapies
- 3.1.3.2. Rising awareness and diagnosis of clotting disorders

Chapter 4. Global Clot Busting Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Clot Busting Drugs Market, by Product

5.1. Market Snapshot
5.2. Global Clot Busting Drugs Market by Product, Performance - Potential Analysis
5.3. Global Clot Busting Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Clot Busting Drugs Market, Sub Segment Analysis
- 5.4.1. Thrombolytic Drugs
- 5.4.2. Anti-Platelet Drugs
- 5.4.3. Anticoagulants
- 5.4.4. Others

Chapter 6. Global Clot Busting Drugs Market, by Indication

6.1. Market Snapshot
6.2. Global Clot Busting Drugs Market by Indication, Performance - Potential Analysis
6.3. Global Clot Busting Drugs Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Clot Busting Drugs Market, Sub Segment Analysis
- 6.4.1. Deep Vein Thrombosis
- 6.4.2. Atrial Fibrillation
- 6.4.3. Pulmonary Embolism
- 6.4.4. Others

Chapter 7. Global Clot Busting Drugs Market, by Route of Administration

7.1. Market Snapshot
7.2. Global Clot Busting Drugs Market by Route of Administration, Performance - Potential Analysis
7.3. Global Clot Busting Drugs Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
7.4. Clot Busting Drugs Market, Sub Segment Analysis
- 7.4.1. Oral
- 7.4.2. Injectable

Chapter 8. Global Clot Busting Drugs Market, by Distribution Channel

8.1. Market Snapshot
8.2. Global Clot Busting Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Clot Busting Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Clot Busting Drugs Market, Sub Segment Analysis
- 8.4.1. Hospital Pharmacy
- 8.4.2. Drug Store
- 8.4.3. Online Pharmacy
- 8.4.4. Retail Pharmacy

Chapter 9. Global Clot Busting Drugs Market, Regional Analysis

9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Clot Busting Drugs Market, Regional Market Snapshot
9.4. North America Clot Busting Drugs Market
- 9.4.1. U.S. Clot Busting Drugs Market
  - 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
  - 9.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
  - 9.4.1.3. Route of Administration breakdown estimates & forecasts, 2020-2030
  - 9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 9.4.2. Canada Clot Busting Drugs Market
9.5. Europe Clot Busting Drugs Market Snapshot
- 9.5.1. U.K. Clot Busting Drugs Market
- 9.5.2. Germany Clot Busting Drugs Market
- 9.5.3. France Clot Busting Drugs Market
- 9.5.4. Spain Clot Busting Drugs Market
- 9.5.5. Italy Clot Busting Drugs Market
- 9.5.6. Rest of Europe Clot Busting Drugs Market
9.6. Asia-Pacific Clot Busting Drugs Market Snapshot
- 9.6.1. China Clot Busting Drugs Market
- 9.6.2. India Clot Busting Drugs Market
- 9.6.3. Japan Clot Busting Drugs Market
- 9.6.4. Australia Clot Busting Drugs Market
- 9.6.5. South Korea Clot Busting Drugs Market
- 9.6.6. Rest of Asia Pacific Clot Busting Drugs Market
9.7. Latin America Clot Busting Drugs Market Snapshot
- 9.7.1. Brazil Clot Busting Drugs Market
- 9.7.2. Mexico Clot Busting Drugs Market
9.8. Middle East & Africa Clot Busting Drugs Market
- 9.8.1. Saudi Arabia Clot Busting Drugs Market
- 9.8.2. South Africa Clot Busting Drugs Market
- 9.8.3. Rest of Middle East & Africa Clot Busting Drugs Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
- 10.1.1. Company 1
- 10.1.2. Company 2
- 10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Bayer AG
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Recent Developments
- 10.3.2. Merck & Co
- 10.3.3. Sun Pharmaceutical Industries Ltd.
- 10.3.4. Johnson & Johnson Services Inc
- 10.3.5. Sanofi-Aventis S.A
- 10.3.6. Boehringer Ingelheim Gmbh
- 10.3.7. Dr. Reddy's Laboratories
- 10.3.8. Genentech Inc.
- 10.3.9. Pfizer Inc.
- 10.3.10. Eli Lilly and Company

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Clot Busting Drugs Market, report scope
TABLE 2. Global Clot Busting Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Clot Busting Drugs Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Clot Busting Drugs Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 5. Global Clot Busting Drugs Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 6. Global Clot Busting Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 7. Global Clot Busting Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Clot Busting Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Clot Busting Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Clot Busting Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Clot Busting Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Clot Busting Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Clot Busting Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Clot Busting Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Clot Busting Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Clot Busting Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Clot Busting Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Clot Busting Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Clot Busting Drugs Market
TABLE 72. List of primary sources, used in the study of global Clot Busting Drugs Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverabl

LIST OF FIGURES

FIG 1. Global Clot Busting Drugs Market, research methodology
FIG 2. Global Clot Busting Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Clot Busting Drugs Market, key trends 2022
FIG 5. Global Clot Busting Drugs Market, growth prospects 2023-2030
FIG 6. Global Clot Busting Drugs Market, porters 5 force model
FIG 7. Global Clot Busting Drugs Market, pest analysis
FIG 8. Global Clot Busting Drugs Market, value chain analysis
FIG 9. Global Clot Busting Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Clot Busting Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Clot Busting Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Clot Busting Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Clot Busting Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Clot Busting Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Clot Busting Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Clot Busting Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Clot Busting Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Clot Busting Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Clot Busting Drugs Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable